| 價格 | 詢價 | ||
| 包裝 | 1支 | 1支 | 1支 |
| 最小起訂量 | 1支 |
| 發(fā)貨地 | 湖北 |
| 更新日期 | 2026-06-10 |
| 英文名稱:Research Grade Domvanalimab (DHH72404) | CAS:2368219-35-4 |
| 純度規(guī)格: PAGE:>95% | 產(chǎn)品類別: 藥物對照抗體 |
| 抗體名: Research Grade Domvanalimab (DHH72404) | 靶點: VSTM3, TIGIT, V-set and transmembrane domain-containing protein 3, VSIG9, V-set and immunoglobulin domain-containing protein 9, T-cell immunoreceptor with Ig and ITIM domains |
| 宿主: Humanized | 適應物種: Human |
| 克隆性: Monoclonal | 藥物對照抗體: Research Grade Domvanalimab (DHH72404) |
Catalog No.
DHH72404
Host species
Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95% by SDS-PAGE.
Clonality
Monoclonal
Isotype
IgG1-Kappa
Applications
Research Grade Biosimilar
Target
VSTM3, TIGIT, V-set and transmembrane domain-containing protein 3, VSIG9, V-set and immunoglobulin domain-containing protein 9, T-cell immunoreceptor with Ig and ITIM domains
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
Q495A1
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
AB-154, CAS: 2368219-35-4
Note
For research use only. Not suitable for clinical or therapeutic use.
| 成立日期 | 2021-04-08 (6年) | 注冊資本 | 500萬 |
| 員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
| 主營行業(yè) | 生物化工,技術服務 | 經(jīng)營模式 | 試劑 |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| 詢價 |
VIP4年
|
江蘇邁凱生物科技有限公司
|
2026-05-18 | |
| 詢價 |
碧云天生物技術有限公司
|
2026-06-09 | ||
| 詢價 |
VIP5年
|
武漢艾美捷科技有限公司
|
2026-06-02 | |
| ¥300 |
VIP1年
|
武漢邁思生物科技有限公司
|
2026-06-08 | |
| ¥2480 |
VIP5年
|
TargetMol中國(陶術生物)
|
2026-04-02 |